Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Microencapsulated ciliary neurotrophic factor : physical properties and biological activities (CROSBI ID 77257)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Maysinger, Dušica ; Krieglstein K. ; Filipović- Grčić, Jelena ; Sendtner, M. ; Unsicker, K. ; Richardson, P. Microencapsulated ciliary neurotrophic factor : physical properties and biological activities // Experimental neurology, 138 (1996), 2; 177-188

Podaci o odgovornosti

Maysinger, Dušica ; Krieglstein K. ; Filipović- Grčić, Jelena ; Sendtner, M. ; Unsicker, K. ; Richardson, P.

engleski

Microencapsulated ciliary neurotrophic factor : physical properties and biological activities

Controlled drug release in the CNS and PNS is still an obstacle to the treatment of neurodegenerative disorders. We have prepared a variety of microspheres containing either ciliary neurotrophic factor (CNTF) or genetically engineered cells able to synthesize and release this cytokine. CNTF is a multifunctional cytokine that can regulate the survival and differentiation of many types of developing and adult neurons. However, when given in therapeutically effective doses by systemic injections, it produces numerous adverse side effects. In order to minimize these effects we have microencapsulated it in biopolymers (chitosans, alginates, and copolymers in various proportions to achieve different kinetic properties). Size distribution profiles were determined by an image analysis system and surface characteristics were assessed by electron microscopy. The total content of CNTF as well as the amounts released per day were determined by ELISA and in vitro bioassays. The results from the release kinetics demonstrate that long-term secretion (up to 24 days) of CNTF is achieved by combining chitosan with copolymerized lactic and glycolic acid, whereas microspheres made of alginate provided only relatively short-term release (2-12 days). Neuron survival and neurite outgrowth in cultures of ciliary ganglia were supported by microencapsulated CNTF, indicating biological stability of CNTF. Genetically engineered human kidney cells 293 continued synthesizing CNTF within spheres and the released amounts of CNTF in the culture medium were comparable to the amounts secreted from monolayers (1 ng/ml of supernatant from confluent cultures) or even higher. These studies provide a basis for future testing of CNTF in encapsulated preparations using animal models of neurodegenerative disorders.

central nervous system ; factor prevents ; adult rat ; cholinergic differentiation ; neuronal differentiation ; embryonic motoneurons ; sympathetic neurons ; alpha component ; cntf receptor ; survival

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

138 (2)

1996.

177-188

objavljeno

0014-4886

1090-2430

Povezanost rada

Farmacija

Indeksiranost